Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine: Safety, tolerability, and effects on cognitive functions in patients with schizophrenia
2004-005078-22Phase 4Completed
- Sponsor
- Hannover Medical School
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of quetiapine in schizophrenia, sponsored by Hannover Medical School. Primary endpoint: Trial completion. Started Apr 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2004-005078-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005078-22.